Literature DB >> 31644919

Chemokine Receptor CCR7 Triggers an Endomembrane Signaling Complex for Spatial Rac Activation.

Julia M Laufer1, Mark A Hauser2, Ilona Kindinger2, Vladimir Purvanov2, Andreas Pauli3, Daniel F Legler4.   

Abstract

Chemokine-guided cell migration is pivotal for many immunological and developmental processes. How chemokine receptor signaling persists to guarantee sustained directional migration despite receptor desensitization and internalization remains poorly understood. Here, we uncover a function for an intracellular pool of the chemokine receptor CCR7 present in human dendritic cells and cellular model systems. We find that CCR7 signaling, initiated at the plasma membrane, is translocated by joint trafficking of β-arrestin and Src kinase to endomembrane-residing CCR7. There, Src tyrosine phosphorylates CCR7, required for the recruitment of Vav1 to form an endomembrane-residing multi-protein signaling complex comprising CCR7, the RhoGEF Vav1, and its effector, Rac1. Interfering with vesicular trafficking affects CCR7-driven cell migration, whereas CCR7:Vav1 interaction at endomembranes is essential for local Rac1 recruitment to CCR7. Photoactivation of Rac1 at endomembranes leads to lamellipodia formation at the cell's leading edge, supporting the role of sustained endomembrane signaling in guiding cell migration.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CCR7; Rac1; Src; Vav1; cell migration; chemokine; endomembrane signaling; β-arrestin

Year:  2019        PMID: 31644919     DOI: 10.1016/j.celrep.2019.09.031

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  11 in total

1.  Shifting CCR7 towards Its Monomeric Form Augments CCL19 Binding and Uptake.

Authors:  Oliver J Gerken; Marc Artinger; Daniel F Legler
Journal:  Cells       Date:  2022-04-25       Impact factor: 7.666

2.  Evaluation of active Rac1 levels in cancer cells: A case of misleading conclusions from immunofluorescence analysis.

Authors:  Martin J Baker; Mariana Cooke; Gabriel Kreider-Letterman; Rafael Garcia-Mata; Paul A Janmey; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2020-08-14       Impact factor: 5.157

Review 3.  The Chemokine Receptor CCR7 Uses Distinct Signaling Modules With Biased Functionality to Regulate Dendritic Cells.

Authors:  José Luis Rodríguez-Fernández; Olga Criado-García
Journal:  Front Immunol       Date:  2020-04-15       Impact factor: 7.561

4.  β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4.

Authors:  Gianluca D'Agostino; Marc Artinger; Massimo Locati; Laurent Perez; Daniel F Legler; Marco E Bianchi; Curzio Rüegg; Marcus Thelen; Adriano Marchese; Marco B L Rocchi; Valentina Cecchinato; Mariagrazia Uguccioni
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

5.  CXCL12 promotes CCR7 ligand-mediated breast cancer cell invasion and migration toward lymphatic vessels.

Authors:  Haruko Hayasaka; Junichi Yoshida; Yasutaka Kuroda; Akihiro Nishiguchi; Michiya Matsusaki; Kei Kishimoto; Hitoshi Nishimura; Mari Okada; Yuki Shimomura; Daichi Kobayashi; Yoshihito Shimazu; Yuji Taya; Mitsuru Akashi; Masayuki Miyasaka
Journal:  Cancer Sci       Date:  2022-02-14       Impact factor: 6.716

Review 6.  New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases.

Authors:  Wenxiang Hong; Bo Yang; Qiaojun He; Jiajia Wang; Qinjie Weng
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

Review 7.  Dendritic cell migration in inflammation and immunity.

Authors:  Juan Liu; Xiaomin Zhang; Yujie Cheng; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2021-07-23       Impact factor: 11.530

8.  ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins.

Authors:  Christoph Matti; Angela Salnikov; Marc Artinger; Gianluca D'Agostino; Ilona Kindinger; Mariagrazia Uguccioni; Marcus Thelen; Daniel F Legler
Journal:  Front Immunol       Date:  2020-04-22       Impact factor: 7.561

9.  Met-RANTES preserves the blood-brain barrier through inhibiting CCR1/SRC/Rac1 pathway after intracerebral hemorrhage in mice.

Authors:  Jun Yan; Weilin Xu; Cameron Lenahan; Lei Huang; Umut Ocak; Jing Wen; Gaigai Li; Wei He; Chensheng Le; John H Zhang; Ligen Mo; Jiping Tang
Journal:  Fluids Barriers CNS       Date:  2022-01-21

10.  CAL-1 as Cellular Model System to Study CCR7-Guided Human Dendritic Cell Migration.

Authors:  Edith Uetz-von Allmen; Guerric P B Samson; Vladimir Purvanov; Takahiro Maeda; Daniel F Legler
Journal:  Front Immunol       Date:  2021-09-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.